Identifying predictors of visual improvement in ethambutol optic neuropathy: insights from a 5-year retrospective analysis in a tertiary clinic in Indonesia.

Valenchia¹, Yunita Mansyur^2,3,4, Alia Arianti¹, Viona⁵

¹Department of Neuro-Ophthalmology, JEC Eye Hospitals and Clinics, Jakarta 14460, Indonesia.

²Department of Neuro-Ophthalmology, JEC Orbita Eye Hospital, Makassar 90245, Indonesia.

³Department of Ophthalmology, Hasanuddin University, Makassar 90245, Indonesia.

⁴Department of Ophthalmology, RSUP Dr.Wahidin Sudirohusodo, Makassar 90245, Indonesia.

⁵Department of Research, JEC Eye Hospitals and Clinics, Jakarta 14460, Indonesia.

PubMed PMC DOI PDF

Abstract

AIM: To characterize the demographic and clinical features of ethambutol optic neuropathy (EON) in an Indonesian patient population and explore prognostic factors for visual recovery. METHODS: Retrospective study of 58 EON patients at an Indonesian eye center (2017-2022). Demographics, ethambutol treatment, ophthalmologic findings were collected. Visual outcomes after ethambutol cessation assesse…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.